Trial Profile
Efficacy Evaluation of In-bare Metal Stent Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter. Study With Intravascular Ultrasound and Optical Coherence Tomography
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Sirolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RESTENOZA
- 24 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Dec 2010 New trial record